Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Noah Lee 2025 Aug 04, 02:20

Trump's Nuclear Rhetoric: Just a Diversion or Real Escalation?

Emma Rose 2025 Aug 04, 01:20

India Defies Trump's Threats, Continues Russian Oil Imports: Energy Security vs. Geopolitics

Sophia Claire 2025 Aug 04, 01:20

Trump's Tariffs on Switzerland: Recession Fears and Potential Deal Adjustments

Bank of England BoE
Tommy Yap 2025 Aug 02, 21:00

Week Ahead: Interest Rate Decisions from BoE in Focus

Forex Indices
Noah Lee 2025 Aug 02, 00:20

Market Review: Trump Tariffs, Fed Rate Hike Expectations, and Mixed Economic Data

Noah Lee 2025 Aug 01, 23:20

Market Review: Trump Tariffs, Fed Policy, Digital Assets, and Key Developments

Ava Grace 2025 Aug 01, 15:20

OPEC+ at a Crossroads: Production Hike and Future Market Challenges

Sophia Claire 2025 Aug 01, 14:20

US Job Growth Slows: Implications for the Federal Reserve

Info

Spread

0.05

Spread (%)

0.7645 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1062523200

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot